Adenosine A3 receptor modulators
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 10, 2002
Grant Date -
N/A
app pub date -
Sep 16, 1998
filing date -
Sep 16, 1998
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The compounds of formula I wherein R, R.sup.1, R.sup.2 R.sup.3 and A have the meanings given in the specification, are endowed with selective A.sub.3 adenosine receptor agonist activity. These compounds can be used in a pharmaceutical composition to treat disorders caused by excessive activation of the A.sub.3 receptor, or can be used in a diagnostic application to determine the relative binding of other compounds to the A.sub.3 receptor.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully